Fig. 1: Utility score from EQ5D questionnaire by trial arm at baseline, 3 months, and 6 months after randomisation. | Nature Communications

Fig. 1: Utility score from EQ5D questionnaire by trial arm at baseline, 3 months, and 6 months after randomisation.

From: Cost-effectiveness of the ReDIRECT/counterweight-plus weight management programme to alleviate symptoms of long COVID

Fig. 1

a Line graph showing mean utility score by trial arm, with standard error shading (n = 118 control, n = 116 intervention), and b box plot showing the distribution of utility scores by trial arm over the trial period (n = 118 control, n = 116 intervention). The box plots show the median (centre line), the first and third quartiles (the lower and upper bounds of the box), and the whiskers show 1.5× the interquartile range. Points beyond the whiskers are ‘outlying’ points plotted individually. Source data are provided with this paper.

Back to article page